---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-165886"
form_type: "8-K"
ticker: "AVIR"
cik: "0001593899"
company_name: "Atea Pharmaceuticals, Inc."
filed_at: "2024-06-21T23:59:59+00:00"
generated_at: "2026-06-01T02:51:13.455097+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Atea Pharmaceuticals re-elects two Class I directors; Berger receives 48% withhold votes

## Summary
- Franklin Berger elected with 30.5M for, 28.3M withheld (48% withhold); Sommadossi elected with 40.8M for, 18.1M withheld.
- KPMG LLP ratified as auditor for FY2024: 62.3M for, 6.5M against, 5.6M abstain.
- Say-on-pay proposal approved on advisory basis: 42.9M for, 15.5M against, 0.4M abstain.
- 88.3% of outstanding shares voted (74.4M of 84.3M shares).

## SEC filing metadata
- accession: 0001193125-24-165886
- form_type: 8-K
- ticker: AVIR
- cik: 0001593899
- company_name: Atea Pharmaceuticals, Inc.
- filed_at: 2024-06-21T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1593899/000119312524165886/0001193125-24-165886-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1593899/000119312524165886/d891172d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-165886
- JSON: https://secwatch.observer/filing/0001193125-24-165886.json
- Plain text: https://secwatch.observer/filing/0001193125-24-165886.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.